Latest Period
n/a
Security Snapshot
AEON Biopharma, Inc. - Class A Common Stock (AEON) Institutional Ownership
CUSIP: 00791X100
13F Institutional Holders and Ownership History from Q3 2023 to Q1 2025
Institutions Reporting
Shares (Excl. Options)
Price
$0.07
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Type / Class
- Equity / Class A Common Stock
- Symbol
- AEON on NYSE
- Shares outstanding
- 39,736,842
- Price per share
- $0.07
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Key facts
- AEON - AEON Biopharma, Inc. - Class A Common Stock is tracked under CUSIP 00791X100.
- Latest finished 13F holder period is not available.
- 4 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 36 to 0 between Q4 2024 and Q1 2025.
- Reported value moved from $4,795,828 to $0.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Schedule 13D/G
Open SEC Evidence
Ownership context comes from Schedule 13D/G and available holder history for this CUSIP.
Security key
00791X100
Latest holder period
n/a
13F holders
13D/G owners
4
CIK / CUSIP context first
AEON full holder history
AEON Biopharma, Inc. SEC filings
AEON Biopharma, Inc. company facts
AEON Biopharma, Inc. insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 00791X100:
Significant Owners of AEON Biopharma, Inc. - Class A Common Stock (AEON) based on Schedule 13D/G filings
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| BIGGER CAPITAL FUND L P | 6.1% | $343,000 | 4,900,000 | Bigger Michael | 06 Jan 2025 | |||
| Blue Owl Capital Holdings LP | 3.8% | $213,455 | 3,049,361 | Blue Owl Capital Holdings LP | 31 Dec 2024 | |||
| PALMISANO ROBERT J | 5.7% | 0% | $158,550 | 2,265,000 | 0% | Robert J Palmisano | 25 Jul 2024 | |
| L1 Capital Global Opportunities Master Fund, Ltd. | 4.1% | -59% | $32,552 | -$594,648 | 465,029 | -95% | L1 Capital Global Opportunities Master Fund, Ltd. | 31 Mar 2025 |
Institutional Holders of AEON Biopharma, Inc. - Class A Common Stock (AEON) across Reporting Periods
| Period | Reported Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2025 Q1 | 0 | $0 | -$4,795,828 | $0.07 | 0 |
| 2024 Q4 | 8,880,478 | $4,795,828 | -$377,954 | $0.54 | 36 |
| 2024 Q3 | 9,572,064 | $10,050,752 | +$4,021,961 | $1.05 | 30 |
| 2024 Q2 | 9,423,837 | $8,730,840 | -$432,476 | $1.05 | 25 |
| 2024 Q1 | 9,471,590 | $103,476,438 | +$9,336,116 | $11.60 | 26 |
| 2023 Q4 | 8,666,712 | $56,800,421 | +$26,503,906 | $7.20 | 20 |
| 2023 Q3 | 4,751,382 | $25,855,744 | +$24,411,072 | $5.60 | 15 |